ES2094542T3 - Derivados de aminoacidos y su utilizacion. - Google Patents

Derivados de aminoacidos y su utilizacion.

Info

Publication number
ES2094542T3
ES2094542T3 ES93910424T ES93910424T ES2094542T3 ES 2094542 T3 ES2094542 T3 ES 2094542T3 ES 93910424 T ES93910424 T ES 93910424T ES 93910424 T ES93910424 T ES 93910424T ES 2094542 T3 ES2094542 T3 ES 2094542T3
Authority
ES
Spain
Prior art keywords
represent
amino acid
acid derivatives
represent hydrogen
nho
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93910424T
Other languages
English (en)
Inventor
Naoyuki Nishikawa
Atsushi Orikasa
Hiroyuki Komazawa
Masayoshi Kojima
Ikuo Saiki
Ichiro Azuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Application granted granted Critical
Publication of ES2094542T3 publication Critical patent/ES2094542T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN DERIVADO DE AMINOACIDO REPRESENTADO POR LA FORMULA GENERAL (I), SU SAL FARMACOLOGICAMENTE ACEPTABLE Y UN INHIBIDOR DE METASTASIS DE CANCER QUE LO CONTIENE, DONDE L1 Y L2 REPRESENTAN UN RESIDUO DE AMINOACIDO, ETC.; A1 Y A3 REPRESENTAN C = O; A2 REPRESENTA ALQUILENO, ETC.; M Y N REPRESENTAN UN ENTERO DE 1 A 5; V REPRESENTA NHC(=NH)NH2, ETC.; W REPRESENTA -COOH, ETC.; R1 Y R2 REPRESENTAN HIDROGENO, ALQUILO, ETC.; R3 Y R4 REPRESENTAN HIDROGENO, ETC.; Y X E Y REPRESENTAN -NHO-. EL DERIVADO TIENE UN POTENTE EFECTO INHIBIDOR DE LAS METASTASIS DE CANCER Y TIENE REDUCIDA ACTIVIDAD EN LA INHIBICION DE AGLUTINACION DE PLAQUETAS Y LA ACTIVIDAD ANTICOAGULANTE.
ES93910424T 1992-06-03 1993-06-01 Derivados de aminoacidos y su utilizacion. Expired - Lifetime ES2094542T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14260792 1992-06-03
JP11984893A JP3274225B2 (ja) 1992-06-03 1993-05-21 アミノ酸誘導体及びその用途

Publications (1)

Publication Number Publication Date
ES2094542T3 true ES2094542T3 (es) 1997-01-16

Family

ID=26457514

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93910424T Expired - Lifetime ES2094542T3 (es) 1992-06-03 1993-06-01 Derivados de aminoacidos y su utilizacion.

Country Status (5)

Country Link
EP (1) EP0644181B1 (es)
JP (1) JP3274225B2 (es)
DE (1) DE69304538T2 (es)
ES (1) ES2094542T3 (es)
WO (1) WO1993024448A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763408A (en) * 1992-06-03 1998-06-09 Fuji Photo Film Co., Ltd. Amino acid derivatives and application thereof
ITRM20010089A1 (it) 2001-02-21 2002-08-21 Idi Irccs Molecole non peptidiche analoghe al peptide rgd con effetto inibitorio sulla adesione, la migrazione e la proliferazione cellulare.
JP6005512B2 (ja) * 2012-12-28 2016-10-12 株式会社タチエス ヘッドレスト
CN106748890B (zh) * 2016-11-24 2018-12-14 南京工业大学 一种l-瓜氨酸琥珀酸盐及其制备方法和应用
CN108948141B (zh) * 2017-05-27 2021-08-24 首都医科大学 3R-吲哚甲基-6S-Pro修饰的哌嗪-2,5-二酮，其合成，活性和应用
CN108929315B (zh) * 2017-05-27 2021-02-12 首都医科大学 3r-吲哚甲基-6s-甲硫氨酸修饰的哌嗪-2,5-二酮，其合成，活性和应用
CN108929314B (zh) * 2017-05-27 2021-02-12 首都医科大学 3r-吲哚甲基-6s-酸性氨基酸修饰的哌嗪-2,5-二酮，其合成，活性和应用
JP2020528891A (ja) * 2017-07-24 2020-10-01 インブリア ファーマシューティカルズ， インコーポレイテッド 変化したｔｃａ回路代謝に関連する状態を処置するための組成物および方法
CN115466250B (zh) * 2021-06-11 2024-06-18 首都医科大学 6-氨基己酰色氨酸苄酯修饰的氧代恶唑烷,其合成,活性和应用
CN116549598A (zh) * 2022-01-29 2023-08-08 华东理工大学 多肽聚合物或多肽模拟物及其在治疗肿瘤中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508508D0 (en) * 1985-04-01 1985-05-09 Creighton A M Pharmaceutical compositions
DE3781263T2 (de) 1986-12-15 1993-04-08 Inst Nat Sante Rech Med Peptid-derivate und deren verwendung in der therapie.
DE3835563A1 (de) 1988-10-19 1990-04-26 Basf Ag Riboflavin-4',5'-cyclo- phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz
EP0492136A3 (en) * 1990-12-20 1993-05-26 American Cyanamid Company Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene
WO1992013552A1 (en) 1991-02-05 1992-08-20 Smithkline Beecham Corporation Anti-aggregatory peptides containing an aromatic ester or amide

Also Published As

Publication number Publication date
JPH0649013A (ja) 1994-02-22
EP0644181B1 (en) 1996-09-04
DE69304538D1 (de) 1996-10-10
JP3274225B2 (ja) 2002-04-15
DE69304538T2 (de) 1997-01-09
EP0644181A4 (en) 1995-07-05
EP0644181A1 (en) 1995-03-22
WO1993024448A1 (fr) 1993-12-09

Similar Documents

Publication Publication Date Title
ES2137628T3 (es) Derivados de estilbeno y composiciones farmaceuticas que los contienen.
ES2104889T3 (es) Derivado de 6-o-metileritromicina a.
MX9206847A (es) Derivados de indolpirrolcarbazol, proceso para su preparacion y medicamento que los contiene
ES2092580T3 (es) Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo.
ES2094542T3 (es) Derivados de aminoacidos y su utilizacion.
FI914566A0 (fi) Antitrombotiska tripeptider.
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
FI930991A0 (fi) Polymerer som innehaoller diesterenheter
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
ES2088574T3 (es) Derivado de anilida.
IT1247878B (it) Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono
CO4950618A1 (es) Inhibidores de proteasas
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
MX9302957A (es) Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DE60016039D1 (de) Verfahren und verbindungen für die hemmung von mrp1
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
FI921562A0 (fi) Gem-difosfonsyror, foerfarande foer framstaellning av dessa och farmaceutiska sammansaettningar som inne- haoller dem.
YU33594A (sh) Postupak za proizvodnju aminoalkilgvanidina
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
DK0668279T3 (da) 6-azaindol thromboxansytaseinhibitor
GT199500058A (es) Inhibidores de la escualeno sintetasa (pc8884aado).
AR012601A1 (es) Derivados de amidina, formulaciones farmaceuticas que los contiene, uso de dichos derivados en la preparacion de medicamentos y proceso para lapreparacion de dichos derivados
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
AR248276A1 (es) Derivados de imidazolidina, procedimiento para producirlos y pesticidas que los contienen
ES2073482T3 (es) Derivados de imidazoquinolona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 644181

Country of ref document: ES